Daisuke Yamane

Title: Daisuke Yamane: Innovator in Dengue Virus Vaccine Development

Introduction

Daisuke Yamane is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the development of vaccines. His innovative work focuses on combating the dengue virus, a major public health concern in many tropical and subtropical regions.

Latest Patents

Daisuke Yamane holds a patent for a recombinant Vaccinia virus that serves as a dengue virus vaccine. This invention can be utilized as both a therapeutic and prophylactic agent in clinical settings. The recombinant Vaccinia virus is characterized by the inclusion of all or part of a cDNA that encodes a non-structural protein from the dengue virus, along with an expression promoter. This groundbreaking approach aims to enhance the effectiveness of dengue virus prevention and treatment.

Career Highlights

Throughout his career, Daisuke Yamane has worked with esteemed institutions such as the Tokyo Metropolitan Institute of Medical Science and Kagoshima University. His research has been pivotal in advancing the understanding and treatment of viral infections, particularly dengue fever.

Collaborations

Daisuke has collaborated with notable colleagues in his field, including Michinori Kohara and Fumihiko Yasui. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Daisuke Yamane's contributions to vaccine development, particularly for the dengue virus, highlight his role as a key innovator in medical science. His work not only addresses a critical health issue but also showcases the importance of collaboration in advancing scientific research.